ES2928251A8 - Medios activados con plasma para uso en el tratamiento de enfermedades respiratorias - Google Patents
Medios activados con plasma para uso en el tratamiento de enfermedades respiratoriasInfo
- Publication number
- ES2928251A8 ES2928251A8 ES202130439A ES202130439A ES2928251A8 ES 2928251 A8 ES2928251 A8 ES 2928251A8 ES 202130439 A ES202130439 A ES 202130439A ES 202130439 A ES202130439 A ES 202130439A ES 2928251 A8 ES2928251 A8 ES 2928251A8
- Authority
- ES
- Spain
- Prior art keywords
- plasma
- treatment
- respiratory diseases
- activated media
- activated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H1/00—Generating plasma; Handling plasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Plasma & Fusion (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202130439A ES2928251B8 (es) | 2021-05-13 | 2021-05-13 | Medios activados con plasma para uso en el tratamiento de enfermedades respiratorias |
| EP22806889.6A EP4338796A4 (en) | 2021-05-13 | 2022-05-05 | Plasma-activated media for use in the treatment of respiratory diseases |
| US18/290,130 US20240350633A1 (en) | 2021-05-13 | 2022-05-05 | Plasma-activated media for use thereof in the treatment of respiratory diseases |
| PCT/ES2022/070275 WO2022238603A1 (es) | 2021-05-13 | 2022-05-05 | Medios activados con plasma para uso en el tratamiento de enfermedades respiratorias |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES202130439A ES2928251B8 (es) | 2021-05-13 | 2021-05-13 | Medios activados con plasma para uso en el tratamiento de enfermedades respiratorias |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| ES2928251A1 ES2928251A1 (es) | 2022-11-16 |
| ES2928251B2 ES2928251B2 (es) | 2025-05-22 |
| ES2928251B8 ES2928251B8 (es) | 2026-04-08 |
| ES2928251A8 true ES2928251A8 (es) | 2026-04-09 |
Family
ID=84028018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES202130439A Active ES2928251B8 (es) | 2021-05-13 | 2021-05-13 | Medios activados con plasma para uso en el tratamiento de enfermedades respiratorias |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240350633A1 (es) |
| EP (1) | EP4338796A4 (es) |
| ES (1) | ES2928251B8 (es) |
| WO (1) | WO2022238603A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140100277A1 (en) * | 2012-10-05 | 2014-04-10 | EP Technologies LLC | Solutions and methods of making solutions to kill or deactivate spores, microorganisms, bacteria and fungus |
| US11844811B2 (en) * | 2018-05-20 | 2023-12-19 | Myfitstrip Llc | Methods and compositions for alleviating respiratory dysfunction |
| CN111494760A (zh) * | 2020-04-14 | 2020-08-07 | 西安交通大学 | 等离子体活性水雾化器 |
-
2021
- 2021-05-13 ES ES202130439A patent/ES2928251B8/es active Active
-
2022
- 2022-05-05 EP EP22806889.6A patent/EP4338796A4/en not_active Withdrawn
- 2022-05-05 US US18/290,130 patent/US20240350633A1/en active Pending
- 2022-05-05 WO PCT/ES2022/070275 patent/WO2022238603A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2928251B8 (es) | 2026-04-08 |
| ES2928251A1 (es) | 2022-11-16 |
| WO2022238603A1 (es) | 2022-11-17 |
| EP4338796A4 (en) | 2025-05-21 |
| ES2928251B2 (es) | 2025-05-22 |
| EP4338796A1 (en) | 2024-03-20 |
| US20240350633A1 (en) | 2024-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000978A1 (es) | Macrociclos peptídicos contra acinetobacter baumannii | |
| MX2021004639A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos. | |
| SV2018005704A (es) | Derivados de 2-fenil-3-(piperazinometil)imidazo[1,2-a]piridina como bloqueadores de los canales task-1 y task-2 para el tratamiento de trastornos respiratorios relacionados con el sueño | |
| MX2017015962A (es) | Uso de exosomas para el tratamiento de enfermedades. | |
| SV2015005115A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
| MX2015003140A (es) | Formulaciones de enzalutamida. | |
| MX2017009449A (es) | Inhibidor jak. | |
| CL2013003051A1 (es) | Compuestos derivados de pirazolo (4.3-d) pirimidinas, inhibidores de quinasa; composicion farmaceutica; y uso para el tratamiento de enfermedades y trastornos del aparato respiratorio | |
| MX378579B (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| BR112019002730A2 (pt) | acetil-leucina, ou um sal farmaceuticamente aceitável da mesma, para uso em um método de tratamento de uma doença neurodegenetativa | |
| UY34278A (es) | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades | |
| CO6842016A2 (es) | Terapia de combinación que comprende un inhibidor de cdk4/6 y un inhibidor de pi3k para el uso en el tratamiento de cáncer | |
| BR112016008016A2 (pt) | inibidores de kras g12c | |
| CL2016003214A1 (es) | Derivados de la indolizina como inhibidores de las fosfoinositido-3 quinasas | |
| PT3481846T (pt) | 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda | |
| UY35687A (es) | Inhibidores de rorc2 y sus métodos de uso | |
| PL3959213T3 (pl) | Pirymidynowe inhibitory JAK w leczeniu chorób skóry | |
| WO2014113407A3 (en) | Use of small molecule inhibitors targeting eya tyrosine phosphatase | |
| MX388722B (es) | Compuestos para tratar el cancer de ovario. | |
| MX2016014859A (es) | Composiciones farmaceuticas que comprenden danirixina para tratar enfermedades infecciosas. | |
| PL3452100T3 (pl) | Nośniki farmaceutyczne zawierające mirna do zastosowania w leczeniu chorób zwłókieniowych spowodowanych hiperglikemią | |
| AR104755A1 (es) | Método para el tratamiento de enfermedad neurológica | |
| CL2021001922A1 (es) | Procedimientos para tratamiento de enfermedades con inhibidores de magl. | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| CL2019002145A1 (es) | Composición farmacéutica que comprende betahistina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC2A | Transfer of patent |
Owner name: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) Effective date: 20220418 |
|
| PC2A | Transfer of patent |
Owner name: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) Effective date: 20220928 |
|
| BA2A | Patent application published |
Ref document number: 2928251 Country of ref document: ES Kind code of ref document: A1 Effective date: 20221116 |
|
| PC2A | Transfer of patent |
Owner name: MEDICAL PLASMAS, S.L. Effective date: 20230301 |
|
| FG2A | Definitive protection |
Ref document number: 2928251 Country of ref document: ES Kind code of ref document: B2 Effective date: 20250522 |